Incordex OverviewLatest ebit for ICDX: $-8.8K, above the sector sector average of $-25M.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025
Incordex posts a EBIT of $-8.8K as of March 2025. That is above the sector sector average of $-25M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a EBIT near $-25M is typical. Incordex's $-8.8K is higher that level. That is roughly 100.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
EBIT is one piece of Incordex's financial statement story. At $-8.8K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for ICDX's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-25M), and (3) consistency with growth and profitability. This page covers the first two; Incordex's other metric pages and overview cover the third.
